Author: Healthcare Propulsion Staff

According to the Office for National Statistics (ONS), there were 6,190 suicides registered in England and Wales in 2024.It remains the biggest cause of death for men under the age of 50 and the rate remains notably higher among males (17.6 per 100,000 people) than females (5.7 per 100,000).A promotional video for On Your Side features England men’s football captain Harry Kane, F1 driver George Russell and Women’s Rugby World Cup winner Rochelle ‘Rocky’ Clark.The toolkit will officially be launched at Everton’s Hill Dickinson Stadium, a venue chosen because its construction included a ‘talking bench’ in memory of former player…

Why do some young adults already show inflammatory patterns usually seen decades later? A large microbiome study traces striking differences in immune and metabolic health to distinct communities of gut bacteria. Study: Gut microbiota composition outperforms chronological age in predicting systemic inflammation and incident disease risk. Image Credit: e-crow / Shutterstock Human gut microbiota composition is more strongly associated with systemic inflammation and a range of physiological measures than chronological age, while specific microbiota profiles are also linked to future disease risk, according to a new study published in the journal Nature Communications. Background Inflammaging is chronic, low-grade inflammation that…

The following is a guest article by Mat Steinlin, Head of Information Security at Aptible Healthcare organizations have gotten better at asking the first AI compliance question: “Will the vendor sign a BAA?” If an AI vendor will create, receive, maintain, or transmit PHI on your behalf, a BAA is foundational. But it’s not a HIPAA certification, a security assessment, or a blanket approval for every feature and workflow you build around that vendor. A BAA governs a defined relationship and a defined scope. Your team still owns the hard part: controlling how PHI moves through the application, who can…

Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, today announced that it has dosed the first patient with Rentosertib (known as ISM001-055 / INS018_055) in GENESIS-IPF-3, a Phase III clinical trial (NCT07687459, CTR20262475) at Peking Union Medical College Hospital, while Shanghai Pulmonary Hospital has also enrolled its first patient on the same day. The Phase III clinical trial is a prospective, multi-center, randomized, double-blind, placebo-controlled, parallel-group study designed to systematically evaluate the efficacy and safety of once-daily Rentosertib administered over 52 weeks. The study is led by Professor Zuojun Xu of Peking Union Medical College Hospital, Chinese Academy…

Healthcare interoperability is seen as a back-office challenge and it is rarely spoken about as a benefit to clinicians. But what if it was? Could it help accelerate initiatives? An initiative in Australia is doing just that. They’re using free and seamless data exchange to reduce screen time so that clinicians can focus more on conversations with patients. Healthcare IT Today sat down with Kirsty Maunder, Senior Business Analyst at CSIRO’s Australian e-Health Research Centre. We discussed their Smart Health Checks initiative, which uses Smart on FHIR technology to reduce data entry and foster human connection at the heart of…

Exposure to light during the nighttime is linked to important and potentially harmful changes to the structure and function of the heart, according to a study of more than 11,000 people published in the European Heart Journal today (Thursday). The research was led by Professor Lu Qi from Tulane University, New Orleans, USA. Previous observational studies have linked nighttime light exposure with a higher risk of cardiovascular disease, but little is known about the related cardiac structure and functional changes. We carried out this research to find out what happens to the heart over time when people are exposed to…

Bruker Corporation today announced a strategic collaboration with Translucence Biosystems, Inc., a leading provider of tissue‑clearing solutions, to expand its workflow for cleared tissue imaging. Through the combined use of Translucence’s Universal Tissue Clearing Kit alongside Bruker’s light‑sheet microscopy and data processing platforms, researchers can move from sample preparation to high-resolution, analysis-ready 3D datasets with greater efficiency and ease. Mouse brain cleared with Universal Tissue Clearing Kit, label IBA1, a microglia marker. Imaged with the Bruker Luxendo LCS SPIM. Image Credit: Bruker The Universal Tissue Clearing Kit is designed to support user-defined antibodies and requires no specialized equipment. Its accessibility and flexibility enable researchers to…

Could a lower, better-tolerated dose of an established muscle relaxant help prevent episodic migraine? A randomized trial tested the approach while exploring whether sex, smoking, and differences in drug exposure might shape treatment response. Study: Effectiveness of tizanidine for migraine prophylaxis: a double-blind, placebo-controlled study. Image Credit: Tunatura / Shutterstock In a recent study published in the journal Scientific Reports, researchers assessed the safety and efficacy of tizanidine for episodic migraine (EM). Migraines affect about 15% of the population worldwide and are the second leading cause of disability. Approximately one-third of patients experience at least two migraine attacks monthly. Frequent attacks…

Radiotherapy UK analysis, shared exclusively with the BBC, suggests more than 3,000 extra patients would need to start treatment every month – a near 15% increase on current numbers – to achieve the March 2027 target.That is likely to grow as referrals keep rising across nearly every cancer type.Price says thousands of patients “are going to die unnecessarily, just because the government can’t get their act together to treat people on time”. For every month a cancer patient waits before starting treatment, their chance of survival falls by around 10%.By the time Alan had his operation, the cancer had spread…

Six different protein-based aging clocks tracked how an experimental IPF drug reshaped biological age signals, revealing a striking disconnect between lung function improvement and broader proteomic responses. Study: Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment. Image Credit: Love Employee / Shutterstock In a recent study published in the journal Nature Biotechnology, a group of researchers determined whether multiple proteomic aging clocks can detect treatment-associated changes in predicted biological age and aging-related proteomic signatures and provided mechanistic insight during a phase 2a trial of rentosertib. Background What if a clinical trial could measure not…